Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (1): 1-11.doi: 10.35541/cjd.20210532

• Guidelines and Consensus • Previous Articles     Next Articles

Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases (2022)

Chinese Society of Dermatology, China Dermatologist Association   

  1. Chinese Society of Dermatology, China Dermatologist Association
  • Received:2021-07-21 Revised:2021-11-02 Online:2022-01-15 Published:2021-12-31
  • Contact: Wang Gang; Jin Hongzhong

Abstract: 【Abstract】 Autoimmune subepidermal bullous diseases mainly include bullous pemphigoid, mucous membrane pemphigoid, cicatricial pemphigoid, pemphigoid gestationis, lichen planus pemphigoides, linear IgA bullous dermatosis, epidermolysis bullosa acquisita, anti-p200/anti-laminin γ1 pemphigoid and dermatitis herpetiformis. Target antigens and pathogenic autoantibodies vary substantially among the above disorders, and there were similarities and differences in their clinical manifestations. Diagnosis and differential diagnosis commonly rely on clinical manifestations, pathological, immunopathological examinations and serum antibody testing. In order to standardize the management of autoimmune subepidermal bullous diseases, Chinese Society of Dermatology and China Dermatologist Association organized experts in this field to develop this consensus based on recent Chinese and international clinical research data, guidelines and consensus.

Key words: Skin diseases, vesiculobullous, Pemphigoid, bullous, Pemphigoid, benign mucous membrane, Diagnosis, Therapy, Autoimmune subepidermal bullous diseases, Expert consensus